Executive Chair & Founding CEO
Karinza Phoenix
Ms Phoenix has more than 24 years of executive and commercial experience in pharmaceutical, veterinary and capital markets sectors, inclusive of holding operational and marketing roles at Pfizer, Novartis and Zoetis. Ms Phoenix has a successful track record of product development, registration and marketing launches, incorporating successful commercialisation of numerous market leading blockbuster medicines. Ms Phoenix has served on the Myopharm Board of Directors for 4 years and has invested in almost all capital raises to date, while focussing on expanding Myopharm’s clinical and commercial initiatives.
Speciality
Executive Chair & Founding CEO
Personal info
Join us at Stocks in the Vines and hear Myopharm's updates:
Myopharm continues to build momentum across its clinical and commercial strategy, with a series of exciting updates expected across its pipeline and development initiatives. As the healthcare and biotech sectors continue to attract strong investor attention, Myopharm is positioning itself at the intersection of innovation and real-world impact.
